Emerging Microbes and Infections (Dec 2022)

SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong

  • Rosana Wing-Shan Poon,
  • Brian Pui-Chun Chan,
  • Wan-Mui Chan,
  • Carol Ho-Yan Fong,
  • Xiaojuan Zhang,
  • Lu Lu,
  • Lin-Lei Chen,
  • Joy-Yan Lam,
  • Vincent Chi-Chung Cheng,
  • Samson S. Y. Wong,
  • Kin-Hang Kok,
  • Kwok-Yung Yuen,
  • Kelvin Kai-Wang To

DOI
https://doi.org/10.1080/22221751.2022.2106899
Journal volume & issue
Vol. 11, no. 1
pp. 2116 – 2119

Abstract

Read online

The SARS-CoV-2 Omicron variant has led to a major wave of COVID-19 in Hong Kong between January and May 2022. Here, we used seroprevalence to estimate the combined incidence of vaccination and SARS-CoV-2 infection, including subclinical infection which were not diagnosed at the acute stage. The overall seropositive rate of IgG against receptor binding domain (anti-RBD IgG) increased from 52.2% in December 2021 to 89.3% in May 2022. The level of anti-RBD IgG was lowest in the 0–9 and ≥80 year-old age groups in May 2022. The seropositive rate of antibody against ORF8, which reflects the rate of prior infection, was 23.4% in May 2022. Our data suggest that although most individuals were either vaccinated or infected after the fifth wave, children and older adults remain most vulnerable. Public health measures should target these age groups in order to ameliorate the healthcare consequences of upcoming waves.

Keywords